Therapeutic plasma exchange combined with intravenous immunoglobulin reduced biological age on average by 2.6 years, as ...

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

The IDMO Smart Factory initiative has the potential to help advance the development and approval of CAR-T therapeutics in ...

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...

The latest imaging method from the Broad Institute uncovers structural disruptions in the nucleus associated with progeria at ...

Mouse models treated with the sleep aid lemborexant had less brain damage compared to controls and mice that received a ...

Replacing PEG with PCB in lipid nanoparticles led to potent mRNA vaccines that avoided unwanted immune responses.

Study suggests gasdermin D inhibition may protect mice by blocking release of cellular contents into the extracellular ...

Early research shows that editing expanding trinucleotide repeats halts the lengthening process that causes neurological ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

A scientist says he has shown that it’s possible to produce a large amount of virus-like particles using a fully scalable ...

Using deep learning techniques, scientists generated an artificial protein that successfully changes its shape to bind and ...